U.S. regulators are taking a first formal step toward addressing emerging contaminants in drinking water, with the Environmental Protection Agency (EPA) and the Department of Health and Human Services (HHS) announcing plans to monitor microplastics and pharmaceuticals. By adding these substances to the sixth Contaminant Candidate List under the Safe Drinking Water Act, authorities will begin systematic testing and research, laying the groundwork for potential future regulation.
The initiative has political and public health dimensions, aligning with the “Make America Healthy Again” agenda promoted by Robert F. Kennedy Jr. and supported by Donald Trump. The announcement also follows mounting pressure from seven U.S. governors and over 175 environmental and health organizations, who petitioned for action after growing concern about widespread microplastic contamination. These particles have been detected in water supplies, ecosystems, and even human tissues, with studies suggesting links to cancer and reproductive harm.
In addition to microplastics, regulators will also monitor pharmaceuticals, which enter water systems through waste and improper disposal. The EPA plans to establish health benchmarks for 374 drugs, further expanding oversight of chemical exposure through drinking water.
To read how a major new study recently revealed that human-made chemicals – from pharmaceuticals and pesticides to plastic additives and industrial compounds – have spread across the entire global ocean, reaching even the most remote waters far from land, see this article on our website.
Popular Blood Pressure Drugs May Trigger Dangerous Seizure-Causing Condition in Older Adults and Women
April 10, 2026Health Officials to Examine if Drugs Used to Treat Parkinson’s Can Lead to Addiction Issues
April 10, 2026US Agencies to Monitor Drinking Water for Microplastics and Pharmaceuticals
News
The U.S. Environmental Protection Agency and Department of Health and Human Services has announced that it will monitor the impact of microplastics and pharmaceuticals on drinking water, the first step toward assessing their health risks and shaping new policies.
[Source: reuters.com]
[Image source: freepik.com]
Comment
U.S. regulators are taking a first formal step toward addressing emerging contaminants in drinking water, with the Environmental Protection Agency (EPA) and the Department of Health and Human Services (HHS) announcing plans to monitor microplastics and pharmaceuticals. By adding these substances to the sixth Contaminant Candidate List under the Safe Drinking Water Act, authorities will begin systematic testing and research, laying the groundwork for potential future regulation.
The initiative has political and public health dimensions, aligning with the “Make America Healthy Again” agenda promoted by Robert F. Kennedy Jr. and supported by Donald Trump. The announcement also follows mounting pressure from seven U.S. governors and over 175 environmental and health organizations, who petitioned for action after growing concern about widespread microplastic contamination. These particles have been detected in water supplies, ecosystems, and even human tissues, with studies suggesting links to cancer and reproductive harm.
In addition to microplastics, regulators will also monitor pharmaceuticals, which enter water systems through waste and improper disposal. The EPA plans to establish health benchmarks for 374 drugs, further expanding oversight of chemical exposure through drinking water.
To read how a major new study recently revealed that human-made chemicals – from pharmaceuticals and pesticides to plastic additives and industrial compounds – have spread across the entire global ocean, reaching even the most remote waters far from land, see this article on our website.
Dr. Rath Health Foundation
Related posts
Vitamin B3 Treatment May Halt Severity of Rare Genetic Disease
Read more